Pharma-Kühlkette — Design, GDP & Validierung
GDP- und WHO-PQ-Lagerdesign: +2/+8 °C- und −20 °C-Zonen, N+1-Redundanz, 21-CFR-Part-11-Monitoring, Mapping und Validierung.
From reading to a project decision
- Who this helps
- Owners, developers and procurement teams considering Pharmaceutical Cold Chain — Design, GDP & Validation Guide.
- Decision supported
- Define product duty, site constraints and comparable scope before selecting equipment or requesting proposals.
- Review status
- A dated technical review is not recorded for every legacy guide. Confirm current product specifications and local requirements with the responsible specialists; no fresh review is implied.
- Free access
- Read, calculate and use checklists without an account, payment or lead submission. Requesting procurement support is optional.
Sizing, temperature and energy checklist
- Record product, packaging, incoming/target temperatures, humidity and permitted excursions from your product specification.
- Record peak stock, daily intake, dwell time, loading schedule and seasonal peaks from your own operating records.
- Confirm grid connection, usable site area, ambient conditions, water and transport interfaces.
- Use declared operating hours, load, tariff and system efficiency; preserve assumptions when comparing scenarios.
- Have the refrigeration engineer and responsible food/pharma quality lead verify the scope before equipment selection.
Destination, season & logistics checklist
A project evidence checklist, not a seasonal forecast. Complete it for each destination using dated operating records, product specifications and responsible local specialists.
- Destination & handoffs
- Record origin, destination, transport mode, loading/unloading points, planned transit and expected waiting time. Identify who monitors temperature and handles excursions at each handoff.
- Season & peak capacity
- Record actual peak months, daily intake, dispatch, dwell time and highest stock from dated records. Label forecasts separately; do not turn an annual national trade indicator into a monthly demand estimate.
- Temperature & energy duty
- Use the product's approved temperature range, incoming temperature, packaging and loading schedule. Record site ambient assumptions, door-opening frequency, power availability and tariff period for capacity and energy comparisons.
- Site & unresolved risks
- Confirm grid, water where required, vehicle access and dock interfaces. Record the evidence owner, source date and unresolved constraint; leave unknown inputs blank rather than presenting them as verified.
Related source material: FAO post-harvest handling manual for food handling context; existing distribution planning guide and site due diligence checklist. This checklist does not establish a food/pharma specification, legal approval or engineered capacity.
Reference library, not verification of every legacy claim: FAO post-harvest management · WHO pharmaceutical temperature mapping, May 2015 · Official regulatory sources. Calculators are preliminary scenarios, not engineering certification or guaranteed results.
Temperature zones & envelope
GDP warehouses combine +2/+8 °C mainstream storage, −20 °C frozen (biologics/APIs) and optionally −70 °C ULT for mRNA. Envelope: 200–350 mm PIR, vapor barrier both sides, sub-floor heating below −5 °C zones.
Refrigeration architecture
Chilled water loop for +2/+8 °C (glycol back-up); NH₃ low-charge or NH₃/CO₂ cascade for −20 °C; discrete ULT cabinets for −70 °C. N+1 minimum; dual utility feeds and diesel N+1 with 72h autonomy.
Monitoring & 21 CFR Part 11
Wireless calibrated loggers (2 per 100 m² min.), central EMS with audit trail, alarm escalation, redundant server + off-site backup. Calibration NIST-traceable, annual re-cal.
Validation programme
URS defines scope and acceptance; DQ against URS; IQ verifies installation; OQ runs empty/loaded challenge; PQ runs seasonal mapping (min. summer + winter, 7-day). Deviation and excursion SOPs follow the applicable GDP guidance (EU GDP 2013/C 343/01; WHO TRS 1025 Annex 7). WHO prequalification covers medical products and immunization equipment, not warehouses.
Procurement pitfalls
Avoid split GC + refrigeration + validation contracts without an integrator — hand-off gaps kill mapping timelines. Bundle EPC + validation partner + monitoring vendor from RFQ stage.
Häufig gestellte Fragen
What redundancy level does GDP require?
GDP does not prescribe N+1; it requires storage conditions to be maintained and excursions managed. Many owners and auditors therefore expect resilient architecture: N+1 chillers, dual utility feeds, backup generator with 72h fuel, and UPS on all monitoring.
Do I need a separate −20 °C room?
Yes for biologics, most vaccines and controlled substances. Envelope separation prevents cross-contamination and simplifies mapping; sharing walls with +2/+8 °C is allowed with proper thermal breaks.
How long does validation take?
Often 6–9 months from IQ start (empty mapping → loaded → seasonal), depending on the owner's quality system and seasons to be mapped. Licensing time varies by national regulator — indicative only, confirm locally.
Kostenlose Lieferantenangebote erhalten
Ein RFQ senden, vorqualifizierte Angebote geprüfter Kälte-EPCs erhalten.
- Industry
- pharmaceutical
- Temperature
- +2/+8 °C and −20 °C
- Budget
- €2M – €25M
- Timeline
- 9–18 months
- Equipment
- GDP-compliant cold rooms, chillers (N+1), EMS monitoring, validation package
Opens the RFQ builder with fields prefilled from this guide — editable before submission.
ColdMatch-Leseupdates erhalten
Fachartikel zu Industriekälte und Kühlkette für Einkäufer, die Projekte planen.
Sie erhalten eine Zusammenfassung neu veröffentlichter Artikel, Leitfäden des Wissenszentrums und Technologie-Briefings zu den gewählten Themen: Titel, Kurzfassungen und Links. Keine Verkaufsangebote oder Lieferantenwerbung.